These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4480067)

  • 1. [Action of a novel anti-inflammatory agent: 804 CB on Masugi type experimental glomerulonephritis].
    Vindel JA; Richer G; Khoury B; Hirbec G
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1378-84. PubMed ID: 4480067
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
    Lagrue G; Masbernard A; Giudicelli C; Hirbec G
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1434-9. PubMed ID: 4614821
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacologic properties of a new, nonsteroidal anti-inflammatory agent, bucloxic acid (804 CB)].
    Navarro J; Stoliaroff M; Savy JM; Berny C; Brunaud M
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1368-78. PubMed ID: 4480066
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new nonsteroidal anti-inflammatory agent: bucloxic acid (804 CB)].
    Krausz F; Breliere JC; Vaillant J; Brunaud M; Navarro J
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1364-7. PubMed ID: 4480065
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of 804 CB and phenylbutazone. Double blind test of venous and arterial pathology].
    Beurey J; Weber M; Toussain P; Jacob M
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1432-4. PubMed ID: 4480072
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of clinical trials of calcium bucloxate (804 CB) in rheumatology].
    de Sèze S; Dryll A; Dreiser R
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1425-8. PubMed ID: 4614819
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experimentation of calcium bucloxate (804 CB) in rheumatology].
    Louyot P; Tamisier JN; Pourel J
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1428-31. PubMed ID: 4614820
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biological surveillance during a test of 804 CB in internal medicine. 120 observations].
    Gallais H; Casanova P
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1442-4. PubMed ID: 4480073
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new anti-inflammatory agent: calcium bucloxate in pediatrics].
    Debray H; Galland A
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1440-2. PubMed ID: 4548650
    [No Abstract]   [Full Text] [Related]  

  • 10. [Calcium bucloxate: its use in ORL inflammatory pathology].
    Gaillard J; Dumolard P
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Feb; 24(2):153-5. PubMed ID: 123947
    [No Abstract]   [Full Text] [Related]  

  • 11. [Non-steroidal anti-inflammatory agents: derivatives of 4-phenylbutyric and 4-phenyl-4-oxobutyric acid].
    Krausz F; Demarne H; Vaillant J; Brunaud M; Navarro J
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1360-4. PubMed ID: 4480064
    [No Abstract]   [Full Text] [Related]  

  • 12. [Masugi hetero-immune nephritis in rats. 3. Histological and ultrastructural study. (Attempt of comparison with protein data)].
    Hartmann L; Bariéty J; Nebut M; Lagrue G
    Ann Biol Clin (Paris); 1969; 27(7):437-50. PubMed ID: 4187677
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immune tolerance in Masugi nephritis].
    Kurunczi S; Mark I
    Zentralbl Pathol; 1993 Mar; 139(1):31-6. PubMed ID: 8499418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study on the activity of various anti-inflammatory agents in chronically developing glomerulonephritis].
    Giudicelli CP; Lagrue G; Masbernard A; Hirbec G
    J Urol Nephrol (Paris); 1975 Sep; 81(9):673-90. PubMed ID: 1243552
    [No Abstract]   [Full Text] [Related]  

  • 15. On the significance of the latent period of Masugi nephritis in rabbits. I. Glomerulonephritis induced in a short period by the combination of nephrotoxic antiserum and bacterial endotoxin.
    Shibata S
    Jpn J Exp Med; 1969 Jun; 39(3):277-86. PubMed ID: 5308530
    [No Abstract]   [Full Text] [Related]  

  • 16. Glomerulonephritis induced in rats by antiserum against a glycoprotein from rat kidney--a new experimental model of glomerulonephritis.
    Shibata S; Nagasawa T; Naruse T; Miyakawa Y
    Jpn J Exp Med; 1967 Aug; 37(4):337-53. PubMed ID: 4872881
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of primary proliferative glomerulonephritis by azathioprine].
    Fries D; Bruna-Blanc N; Banssillon V; Zech P; Touboul P; Canarelli G; Traeger J
    J Urol Nephrol (Paris); 1968 Dec; 74(12):1012-21. PubMed ID: 4886358
    [No Abstract]   [Full Text] [Related]  

  • 18. Purpura followed by proteinuria in a 7-year-old girl.
    Lau KK; Wyatt RJ; Gaber LW
    Am J Kidney Dis; 2005 Dec; 46(6):1140-4. PubMed ID: 16310581
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of several parameters of hemostasis in Masugi's rabbit nephritis].
    Lagrue G; Levent M; Gouault-Heilmann M; Hirbec G; Branellec A
    Pathol Biol (Paris); 1975 Feb; 23(2):139-44. PubMed ID: 1093104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent Masugi nephritis induced in rats in spite of the suppression of host antibody responses against the heterologous nephrotoxic antibodies.
    Shimizu F
    Jpn J Exp Med; 1974 Oct; 44(5):443-9. PubMed ID: 4140253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.